485 related articles for article (PubMed ID: 32708653)
1. Resolvin D1 and D2 Inhibit Transient Receptor Potential Vanilloid 1 and Ankyrin 1 Ion Channel Activation on Sensory Neurons via Lipid Raft Modification.
Payrits M; Horváth Á; Biró-Sütő T; Erostyák J; Makkai G; Sághy É; Pohóczky K; Kecskés A; Kecskés M; Szolcsányi J; Helyes Z; Szőke É
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708653
[TBL] [Abstract][Full Text] [Related]
2. Evidence for the role of lipid rafts and sphingomyelin in Ca2+-gating of Transient Receptor Potential channels in trigeminal sensory neurons and peripheral nerve terminals.
Sághy É; Szőke É; Payrits M; Helyes Z; Börzsei R; Erostyák J; Jánosi TZ; Sétáló G; Szolcsányi J
Pharmacol Res; 2015 Oct; 100():101-16. PubMed ID: 26238178
[TBL] [Abstract][Full Text] [Related]
3. The role of free fatty acid receptor pathways in a selective regulation of TRPA1 and TRPV1 by resolvins in primary sensory neurons.
Pyo HJ; An X; Cho H
J Cell Physiol; 2022 Sep; 237(9):3651-3660. PubMed ID: 35802479
[TBL] [Abstract][Full Text] [Related]
4. Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: distinct roles of resolvin D1, D2, and E1.
Park CK; Xu ZZ; Liu T; Lü N; Serhan CN; Ji RR
J Neurosci; 2011 Dec; 31(50):18433-8. PubMed ID: 22171045
[TBL] [Abstract][Full Text] [Related]
5. A novel 3-(4,5-diphenyl-1,3-oxazol-2-yl)propanal oxime compound is a potent Transient Receptor Potential Ankyrin 1 and Vanilloid 1 (TRPA1 and V1) receptor antagonist.
Payrits M; Sághy É; Mátyus P; Czompa A; Ludmerczki R; Deme R; Sándor Z; Helyes Z; Szőke É
Neuroscience; 2016 Jun; 324():151-62. PubMed ID: 26930003
[TBL] [Abstract][Full Text] [Related]
6. Propofol restores transient receptor potential vanilloid receptor subtype-1 sensitivity via activation of transient receptor potential ankyrin receptor subtype-1 in sensory neurons.
Zhang H; Wickley PJ; Sinha S; Bratz IN; Damron DS
Anesthesiology; 2011 May; 114(5):1169-79. PubMed ID: 21364461
[TBL] [Abstract][Full Text] [Related]
7. Antimycin A-induced mitochondrial dysfunction activates vagal sensory neurons via ROS-dependent activation of TRPA1 and ROS-independent activation of TRPV1.
Stanford KR; Hadley SH; Barannikov I; Ajmo JM; Bahia PK; Taylor-Clark TE
Brain Res; 2019 Jul; 1715():94-105. PubMed ID: 30914247
[TBL] [Abstract][Full Text] [Related]
8. Effect of lipid raft disruption on TRPV1 receptor activation of trigeminal sensory neurons and transfected cell line.
Szoke E; Börzsei R; Tóth DM; Lengl O; Helyes Z; Sándor Z; Szolcsányi J
Eur J Pharmacol; 2010 Feb; 628(1-3):67-74. PubMed ID: 19958765
[TBL] [Abstract][Full Text] [Related]
9. The omega-3 lipid 17,18-EEQ sensitizes TRPV1 and TRPA1 in sensory neurons through the prostacyclin receptor (IP).
Schäfer SMG; Sendetski M; Angioni C; Nüsing R; Geisslinger G; Scholich K; Sisignano M
Neuropharmacology; 2020 Apr; 166():107952. PubMed ID: 31955004
[TBL] [Abstract][Full Text] [Related]
10. Carboxamido steroids inhibit the opening properties of transient receptor potential ion channels by lipid raft modulation.
Sághy É; Payrits M; Bíró-Sütő T; Skoda-Földes R; Szánti-Pintér E; Erostyák J; Makkai G; Sétáló G; Kollár L; Kőszegi T; Csepregi R; Szolcsányi J; Helyes Z; Szőke É
J Lipid Res; 2018 Oct; 59(10):1851-1863. PubMed ID: 30093524
[TBL] [Abstract][Full Text] [Related]
11. Functional Transient Receptor Potential Ankyrin 1 and Vanilloid 1 Ion Channels Are Overexpressed in Human Oral Squamous Cell Carcinoma.
Kiss F; Kormos V; Szőke É; Kecskés A; Tóth N; Steib A; Szállási Á; Scheich B; Gaszner B; Kun J; Fülöp G; Pohóczky K; Helyes Z
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163843
[TBL] [Abstract][Full Text] [Related]
12. A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1.
Cevikbas F; Wang X; Akiyama T; Kempkes C; Savinko T; Antal A; Kukova G; Buhl T; Ikoma A; Buddenkotte J; Soumelis V; Feld M; Alenius H; Dillon SR; Carstens E; Homey B; Basbaum A; Steinhoff M
J Allergy Clin Immunol; 2014 Feb; 133(2):448-60. PubMed ID: 24373353
[TBL] [Abstract][Full Text] [Related]
13. Role of calcium ions in the positive interaction between TRPA1 and TRPV1 channels in bronchopulmonary sensory neurons.
Hsu CC; Lee LY
J Appl Physiol (1985); 2015 Jun; 118(12):1533-43. PubMed ID: 25858491
[TBL] [Abstract][Full Text] [Related]
14. Sensory nerve terminal mitochondrial dysfunction activates airway sensory nerves via transient receptor potential (TRP) channels.
Nesuashvili L; Hadley SH; Bahia PK; Taylor-Clark TE
Mol Pharmacol; 2013 May; 83(5):1007-19. PubMed ID: 23444014
[TBL] [Abstract][Full Text] [Related]
15. Analgesic Effects of Lipid Raft Disruption by Sphingomyelinase and Myriocin via Transient Receptor Potential Vanilloid 1 and Transient Receptor Potential Ankyrin 1 Ion Channel Modulation.
Horváth Á; Payrits M; Steib A; Kántás B; Biró-Süt T; Erostyák J; Makkai G; Sághy É; Helyes Z; Szőke É
Front Pharmacol; 2020; 11():593319. PubMed ID: 33584270
[TBL] [Abstract][Full Text] [Related]
16. Allyl isothiocyanate sensitizes TRPV1 to heat stimulation.
Alpizar YA; Boonen B; Gees M; Sanchez A; Nilius B; Voets T; Talavera K
Pflugers Arch; 2014 Mar; 466(3):507-15. PubMed ID: 23955021
[TBL] [Abstract][Full Text] [Related]
17. Possible involvement of transient receptor potential ankyrin 1 in Ca
Nishizawa Y; Takahashi K; Oguma N; Tominaga M; Ohta T
J Neurosci Res; 2018 May; 96(5):901-910. PubMed ID: 29282753
[TBL] [Abstract][Full Text] [Related]
18. Identification of molecular targets for toxic action by persulfate, an industrial sulfur compound.
Shimada T; Takahashi K; Tominaga M; Ohta T
Neurotoxicology; 2019 May; 72():29-37. PubMed ID: 30738091
[TBL] [Abstract][Full Text] [Related]
19. Transient Receptor Potential Ankyrin 1 Ion Channel Is Expressed in Osteosarcoma and Its Activation Reduces Viability.
Hudhud L; Rozmer K; Kecskés A; Pohóczky K; Bencze N; Buzás K; Szőke É; Helyes Z
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612571
[TBL] [Abstract][Full Text] [Related]
20. Maresin 2 is an analgesic specialized pro-resolution lipid mediator in mice by inhibiting neutrophil and monocyte recruitment, nociceptor neuron TRPV1 and TRPA1 activation, and CGRP release.
Fattori V; Zaninelli TH; Ferraz CR; Brasil-Silva L; Borghi SM; Cunha JM; Chichorro JG; Casagrande R; Verri WA
Neuropharmacology; 2022 Sep; 216():109189. PubMed ID: 35820471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
